Procode Secures $10M to Scale AI-Powered Surgical Revenue Cycle Management
Health Velocity CapitalCompany
Procode Inc. closed a $10 million Series A round on July 28, 2026, led by Health Velocity Capital, bringing its total venture funding to $14 million. The capital will fund two bolt‑on acquisitions of private‑practice billing agencies and accelerate rollout of its AI‑driven surgical revenue cycle management platform.
Procode Inc. secured a $10 million Series A financing on July 28, 2026, with Health Velocity Capital as the lead investor. The round lifts the company’s cumulative venture backing to $14 million and is earmarked for two strategic acquisitions of boutique billing agencies that serve private‑practice surgeons and ambulatory surgical centers (ASCs).## Deal Terms The Series A was disclosed as a pure equity infusion; valuation multiples were not disclosed. Procode will deploy the proceeds to integrate its proprietary AI engine, Procollect operating system, and the Auctus Provider App into the acquired agencies, creating a unified, specialty‑focused revenue cycle management (RCM) stack.## Strategic Rationale Procode’s platform combines a fine‑tuned hybrid large language model that extracts CPT/ICD codes from operative reports, an automation‑rich billing OS, and a mobile provider portal. A retrospective study published in *PRS Global Open* showed the AI achieved 86.7% overall coding accuracy, outpacing human auditors (42.5%) and generic LLMs. By layering this technology over existing agency workflows, Procode aims to reduce denial rates, shorten days in accounts receivable, and capture more reimbursement dollars for surgeons who operate on a contingency‑based billing model. The acquisitions will expand the company’s footprint beyond its initial Auctus Group purchase, which already covers over 350 plastic‑surgery and dermatology providers, into broader surgical subspecialties and additional ASC networks. The capital raise also positions Procode to compete more aggressively against enterprise hospital‑system RCM solutions that have historically dominated the market, while offering a SaaS‑first, specialty‑tailored alternative for private practices.
Why It Matters
For Procode, the Series A provides the runway to transition from a single‑practice playbook to a roll‑up strategy that consolidates fragmented specialty billing agencies under a unified AI platform. The acquisitions will immediately increase recurring subscription revenue and create cross‑sell opportunities for Procollect and the Auctus Provider App, accelerating net revenue retention. Competitors that rely on generic LLMs or manual coding will face pressure as Procode’s demonstrated accuracy gains translate into higher collection ratios for providers, a compelling value proposition in a market where denial rates remain high. The infusion also validates the contingency‑based model, signaling to other health‑tech investors that AI‑enhanced RCM can be monetized through performance‑linked contracts rather than pure software licensing.
Key Points
- Procode raised $10 million in a Series A led by Health Velocity Capital
- Total venture funding now stands at $14 million
- Funds will finance two acquisitions of private‑practice billing agencies
- AI engine achieved 86.7% coding accuracy in a peer‑reviewed study
- The rollout targets expansion from plastic‑surgery/dermatology into broader ASC and surgical subspecialties
Analysis
The $10 million Series A places Procode at a valuation frontier for niche AI‑driven RCM firms, where multiples typically range from 8‑12 x ARR for high‑growth SaaS platforms. Assuming a modest ARR of $5 million post‑acquisition, the implied multiple would be roughly 10 x, aligning with market expectations for specialty‑focused health‑tech. The capital enables a roll‑up play that can lift the combined revenue base, improve gross margins through AI‑driven automation, and accelerate net revenue retention as existing agency clients adopt Procollect and the Auctus Provider App. For investors, the deal underscores a broader shift: capital is flowing toward domain‑specific AI solutions that address high‑complexity billing bottlenecks rather than generic hospital‑wide platforms. Operators can expect tighter integration of AI coding engines into everyday practice workflows, reducing days in A/R and boosting provider cash flow. As more private practices adopt contingency‑based billing models, AI accuracy becomes a direct lever for revenue growth, making Procode’s approach a template for future health‑tech roll‑ups targeting fragmented specialty markets.